Belgium: Defensive actions in UPC and national courts

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Belgium: Defensive actions in UPC and national courts

The opt‐out possibility offered by Article 83 UPCA pays lots of attention to the choices patentees are facing with regards to their filing strategy. We focus here on defensive strategies in the new legislative framework, in particular on actions before national courts.

Coexistence between the UPC and national jurisdictions during the transitional period is governed by the UPCA and by the Brussels Regulation (Recast) (EU) 1215/2012.

Article 83.3 UPCA establishes the right to opt‐out (completely) of the UPC.

Article 83.4 UPCA further stipulates that unless an action has already been brought before a national court, proprietors of or applicants for European patents who made use of the opt‐out in accordance with paragraph 3 shall be entitled to withdraw their opt‐out at any moment.

Thus, if an invalidity action before a national court exists, patentees will not be able to use the UPC at all, including an infringement action.

Is such a legal effect compatible with the Brussels Regulation? Not sure. It is true that under the Regulation, the court first seized retains jurisdiction when the same action, involving the same parties, is subsequently filed in another EU court. Consequently, the existence of an invalidity action in a national court should not prevent the use of the UPC for an infringement action.

In any event, Article 83 deals with the specific opt‐out context. But what about the more general context, namely the impact of an existing action before a national court, where no opt‐out has been requested?

Furthermore, what is the impact of actions before national courts pending at the time of the UPC inception?

These uncertainties make it difficult for parties to implement a defensive strategy. Is it worth investing in an invalidity action in a national court, before entry into force of the UPC? Assuming such an action impacts patentees' choices at all, will it completely prevent the use of the UPC or only preclude the use of the UPC for a nullity action?

Canonici

Jean‐Jacques Canonici


Gevers & OresHolidaystraat, 5B-1831 Diegem - BrusselsBelgiumTel: +32 2 715 37 11Fax: +32 2 715 37 00www.gevers.eu

more from across site and SHARED ros bottom lb

More from across our site

A Tokyo District Court ruling concerning movie spoilers, and a second chance for VLSI against Intel were also among the top talking points
Practitioners believe new AI tools at the USPTO will not replace lawyers or disrupt revenue, but instead expose where a trademark attorney’s value lies
Leighton Cassidy Legal hopes to leverage its founder's international experience and provide clients with a rare chance to receive litigation and prosecution under one umbrella
UKIPO rejects trademark application for 'Cristiano Ronaldo Origins' following opposition by Beck Greener client in a rare case that considered actual use
Partners at both firms have voted in favour of the tie-up, which marks ‘the largest law firm merger in history’
Head of IP, Andrew Brennan, and new partner, France Delord, explain how tech provides an edge in the battle for global brand owners’ business
Anton Hopen, shareholder at Trenam Law, shares how counsel should construct Section 101 claims as early 2026 PTAB data shows reversals rising in technical cases
Law firms should consider how they can help clients, as report calls on EU to use IP-backed financing to increase bloc’s competitiveness and attractiveness for businesses
In the final part of a series on challenging patent invalidation decisions in China, lawyers at Spruson & Ferguson and Marshall Gerstein share how courts adjudicate appeals
Stijn Debaene and Carina Gommers want Brussels-based Cast Law to be the place 'everybody wants to work'
Gift this article